Validation experiment designed to validate causal mechanisms targeting HMGCS2 in C57BL/6 mice with AECII-specific gene delivery. Primary outcome: pulmonary fibrosis severity
Mice with AECII-specific HMGCS2 overexpression were generated using an AAV (adeno-associated virus) delivery system to investigate the therapeutic potential of HMGCS2 in experimental pulmonary fibrosis. The study demonstrated that ectopic expression of HMGCS2 in AECIIs significantly alleviated experimental mouse lung fibrosis progression. The mechanism involved modulation of lipid degradation in AECIIs through promoting CPT1A and CPT2 expression via interaction with PPARα transcription factor.
AAV-mediated AECII-specific HMGCS2 overexpression, bleomycin-induced fibrosis model, histological and molecular analysis
Reduced pulmonary fibrosis progression and improved lung function
Significant reduction in fibrosis markers and improved lung architecture
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.